Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.
about
Circulating serologic and molecular biomarkers in malignant melanomaSerum peptidome variations in a healthy population: reference to identify cancer-specific peptidesHuman body fluid proteome analysis.Proteomic identification and profiling of canine lymphoma patients.Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in parkinson's disease.Novel multifunctional chitosan-GMA-IDA-Cu(II) nanospheres for high dynamic range characterization of the human plasma proteome.Chemically modified diamond-like carbon (DLC) for protein enrichment and profiling by MALDI-MS.Acute phase reactants, challenge in the near future of animal production and veterinary medicine.Current concepts of metastasis in melanoma.Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.Proteomics in melanoma biomarker discovery: great potential, many obstacles.Development of new multifunctional terpolymer sorbent for proteomics applications.New Perspectives of "omics" Applications in Melanoma Research.Chemotherapy-induced neutropenia during adjuvant treatment for cervical cancer patients: development and validation of a prediction model.Bioinformatics approaches in clinical proteomics.Translating genomic biomarkers into clinically useful diagnostics.Tumor-associated antigen arrays for the serological diagnosis of cancer.Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay.Growth factors and oncogenes as targets in melanoma: lost in translation?Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling.Applications of machine learning in cancer prediction and prognosisBiomarkers in melanoma.Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma.Cutaneous melanoma: a model to study cancer metastasis.Prognostic tissue markers in melanoma.Blood biomarkers for uveal melanoma.Protein and non-protein biomarkers in melanoma: a critical update.Liquid biomarkers in melanoma: detection and discovery.
P2860
Q27020946-469268E9-513B-43EA-8170-D7E79A59708BQ28397855-646B5A26-E510-4CC9-B474-507679830357Q33262623-3D3D350C-01D5-4311-B8AF-348B6CB0A67EQ33447697-E2DBE9BF-A6E9-4A9D-9C6A-0F9759DB3F9CQ33805846-21D3C9A8-9647-4FD1-878B-6A08089A84E7Q33836933-5345F173-B914-48F6-B1A9-DEA7CF01548AQ34073549-6D6781DB-D749-4E50-B973-BA758C979C3AQ34426539-706D0541-78A8-494F-AE72-2406C0A5273AQ34610427-7A6E8360-7081-40A0-A523-336BE75D661CQ34842139-E5DEDAD8-A77E-4426-856D-AE52DF0C1B62Q35374035-391C9AF0-4BBD-4C23-AE14-19F71D86CDBFQ35426621-2857F521-F5F3-435F-AE12-850A5F2333EEQ35670683-E5B69C9F-F45F-4C91-9BE8-9C1873625508Q36046284-365FBF75-7C4C-49D7-83BB-854047F10594Q36322145-4387C32D-9565-4B33-9FE8-DD2D1AB1E9A1Q36411676-20182B7E-7FB5-4BA8-A935-2F45C1DB25A4Q36491988-1DBCDE77-F6FA-480F-A79F-7CA9846A5FE5Q36707344-EAA59AEF-A47C-44EF-AA12-29F7CDFD649AQ36893247-98067868-C3AC-4769-A91B-C9A85710CAB9Q37045217-ABAFB745-A5B8-4463-A130-D653A8B363D0Q37114841-FC31BB23-1675-4D3D-8FE3-07C2301F47E3Q37175004-D3584873-DBAD-4F93-923E-9CD8D008B667Q37555801-F7B9A46C-DB78-4135-BD98-8130BE69C971Q37801939-E93AC74B-57F7-4CA4-A586-429150918FCCQ37863622-0D529BB6-3595-4FCB-8639-E99DF8DC351EQ37924320-DC6CB77D-B065-485D-B025-0BFF448D6A3CQ37984126-589C2A9D-55B1-4999-B763-196168FC60A1Q38050990-47BCEC82-B6EE-42F5-89A1-B4CE873FF5C2Q47726847-7AD0377C-FD3C-427E-A304-B4AEFEF2A454
P2860
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Serum proteomic fingerprinting ...... gression in melanoma patients.
@ast
Serum proteomic fingerprinting ...... gression in melanoma patients.
@en
Serum proteomic fingerprinting ...... gression in melanoma patients.
@en-gb
type
label
Serum proteomic fingerprinting ...... gression in melanoma patients.
@ast
Serum proteomic fingerprinting ...... gression in melanoma patients.
@en
Serum proteomic fingerprinting ...... gression in melanoma patients.
@en-gb
prefLabel
Serum proteomic fingerprinting ...... gression in melanoma patients.
@ast
Serum proteomic fingerprinting ...... gression in melanoma patients.
@en
Serum proteomic fingerprinting ...... gression in melanoma patients.
@en-gb
P2093
P50
P356
P1476
Serum proteomic fingerprinting ...... gression in melanoma patients.
@en
P2093
Erika Parkinson
Graham Ball
Iris Schlenzka
Robert Rees
Shahid Mian
P304
P356
10.1200/JCO.2005.03.164
P407
P577
2005-08-01T00:00:00Z